Crea sito

Drugs Update !

Drugs – DrugsNews.net

DrugsNews.net, Drugs News, Drugs Newsletter  Xagena … Drugs News, AZ Guide on Drugs, Newsletter Drugs, Pharmacology Newsletter, PharmAlert Newsletter, Pharmacovigilance

Enoxaparin

Edoxaban versus Enoxaparin in preventing venous …

Bortezomib

The FDA ( Food and Drug Administration ) has approved …

DrugsNews.net – Drugs Xagena

Provenge, the first autologous cellular immunotherapy for …

Actos

Long-term treatment with Actos: increased incidence of …

Metastatic colorectal cancer

It is used to treat metastatic colorectal cancer in adults who …

Label expansion for Lumizyme …

Label expansion for Lumizyme in the … in the United States …

Drugs Xagena

Afinitor in advanced renal cell carcinoma after failure of …

Divalproex

Children exposed in utero: Valproate, Valproic acid and …

retreatment in patients with …

Velcade: retreatment in patients with multiple myeloma …

Jakafi

Ruxolitinib ( Jakafi ) is an oral, selective inhibitor of Janus …

Medical Therapy News

Drugs – DrugsNews.net

PharmAlert, FarmAlert, Farmacovigilanza Newsletter, Newsletter Farmacosorveglianza, DrugsNews.net, Drugs News, Drugs Newsletter, Drugs News, AZ Guide on Drugs, Newsletter Drugs, Pharmacology Newsletter, PharmAlert Newsletter, Pharmacovigilance, Farmacologia :: Novità, Farmaci :: Novità,  
Enoxaparin

Edoxaban versus Enoxaparin in preventing venous …
Bortezomib

The FDA ( Food and Drug Administration ) has approved …
DrugsNews.net – Drugs Xagena

Provenge, the first autologous cellular immunotherapy for …
Actos

Long-term treatment with Actos: increased incidence of …
Metastatic colorectal cancer

It is used to treat metastatic colorectal cancer in adults who …
Label expansion for Lumizyme …

Label expansion for Lumizyme in the … in the United States …
Drugs Xagena

Afinitor in advanced renal cell carcinoma after failure of …
Divalproex

Children exposed in utero: Valproate, Valproic acid and …
retreatment in patients with …

Velcade: retreatment in patients with multiple myeloma …
Jakafi

Ruxolitinib ( Jakafi ) is an oral, selective inhibitor of Janus …

Guide to Medicine

Medicine & Drugs – Xagena.net

Medicine, Medical News, Xagena Medical News, Medicine Newsletter, Updates in Medicine, Drugs Focus, Drugs Newsletter, Medicina, Xagena Medical News, Xagena.net, Xagena News,  Medicine News, AZ Guide Medicine, Specialty :: Allergology, Andrology, Cardiology, Dermatology, Diabetology, Diagnostics, Oncology, Medical Therapy, Biomedicine,  
  1. Alemtuzumab

    Search results for “Alemtuzumab” … to Fludarabine and …
    Dabrafenib

    The FDA ( Food and Drug Administration ) has approved …
    Inflectra

    Inflectra the first biosimilar monoclonal antibody to be …
    Perjeta

    Perjeta for neoadjuvant breast cancer … approval to Perjeta …
    Kadcyla

    Kadcyla for advanced HER2-positive breast cancer …
    Lynparza

    Search results for “Lynparza” … marketing authorisation of …
    Pertuzumab

    Women with HER2+ breast cancer: Pertuzumab and Trastuzumab …
    Paclitaxel

    Search results for “Paclitaxel” … Abraxane ( Paclitaxel protein …
    Moventig

    Search results for “Moventig” … approval of Moventig …
    Digoxin

    Digoxin, a drug commonly used to treat heart conditions, was …